Filter Results:
(561)
Show Results For
- All HBS Web
(561)
- People (4)
- News (144)
- Research (345)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(561)
- People (4)
- News (144)
- Research (345)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the 1990s, the U.S. and European... View Details
- Fast Answer
Pharmaceuticals: Pipeline
Profiles cover detailed information such as alternative names, therapeutic uses, FDA actions and licensing changes, companies associated with development of the drug, etc. To begin a search, use the function BI PHRM DEX, select... View Details
- 01 Mar 2012
- News
How to Close the Health Gap
companies largely ignored the world’s poor: few new drugs were created to combat tropical diseases and TB. The needs of the developing world also were neglected by the Human Genome Project, one of the great... View Details
- 01 Jun 2000
- News
The Business of Biotech
"blockbusters" will disappear. Recent developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The... View Details
Keywords: Julia Hanna
- 01 Jan 2009
- News
Kathryn E. Giusti, MBA 1985
aided in the development of drugs for this and other cancers. A successful marketing executive who had worked at Merck, Gillette, and Searle, Giusti was diagnosed with myeloma in 1996. As she faced a grim... View Details
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
graduation from Harvard Business School and which successfully developed and commercialized a market-leading drug to treat cardiovascular disease. But in addition to drawing on technical degrees and... View Details
Keywords: Deborah Blagg
- 04 Sep 2019
- News
Deep Dive
manage a worldwide team to develop a virtual product—diving to the bottom of all five oceans, and doing a lot of science along the way.” The Five Deeps Expedition, Vescovo said, has “proven to be as challenging as any business thing I’ve... View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
pharmaceuticals, it concentrated on enlarging its OTC business by, as before, exploiting its advertising skills. By 1979 it had developed a broader line of new prescription drugs, beginning in 1968 with Inderal, a beta-blocker View Details
William B. Bell
Bell diversified American Cyanamid, developing the company into the 5th largest producer of chemicals in the U.S., manufacturing over 5,000 products. Bell developed new processes for the commercial... View Details
Keywords: Chemicals & Industrial
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new products to the marketplace, even as... View Details
Josiah K. Lilly
Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the company... View Details
Keywords: Healthcare
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The View Details
- Fast Answer
Biotech and Pharmaceuticals: R&D spending, production cost
can be found in company’s income statement that can be found in Capital IQ ABI/ProQuest - To locate articles on the topic, use search terms: drug development cost (drug development) AND (success... View Details
- 07 Oct 2014
- News
Network Effect
was shocked by their advice. “They said, ‘Try three Advil a day. It might help. There are a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had... View Details
Keywords: Linda Kush
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
product and service development is changing; creating the potential for higher R&D performance, innovation, and value creation for customers. The choice is simple: Organizations can either ignore these changes or take action and tap... View Details
Keywords: by Wendy Guild
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care.... View Details
Ernest H. Volwiler
Volwiler was a pioneer in the field of anesthetic medicine, developing two breakthrough drugs, Nembutal and Pentothal, which put patients to sleep for surgical or dental procedures. Beyond his brilliance as a scientist, Volwiler was... View Details
Keywords: Healthcare
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
Richard M. Furlaud
Furlaud focused on Squibb's pharmaceuticals, investing in research and development that ultimately led to the introduction of several new drugs. Furlaud's streamlining and consistent support of the company's cardiovascular View Details
Keywords: Healthcare